{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:42:36Z","timestamp":1760100156046},"reference-count":31,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T00:00:00Z","timestamp":1236211200000},"content-version":"vor","delay-in-days":11266,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vox Sanguinis"],"published-print":{"date-parts":[[1978,5]]},"abstract":"<jats:p><jats:bold>Abstract.<\/jats:bold> The use of a gelatin plasma substitute as an integral part of a unified national program for the procurement of blood components and derivatives paves the way for the extensive use of red cell concentrates in the treatment of hemorrhage, the plasma from the original donations being partly diverted to the fractionation program of a national transfusion service. We estimated the potential of such a system paced by the demand for red cells and predicted that the use of 20% of fresh whole blood and 80% concentrates would not increase the demand for albumin, the yield of which would suffice to cover three\u2010quarters of current needs in our country. The actual performance of a program using 85% of red cell concentrates in a university hospital with an exceptionally high incidence of major hemorrhage was analyzed in detail. The use of albumin per unit of transfused red cells rose by 9%. With a nationwide increase of this magnitude, 67% of the demand in our country could still be met and the estimated true need for albumin of 200 kg per million inhabitants and year would be fully covered. The yield of factor VIII is 200\u2013300% of the demand. The determinants of the effects of such a system vary from country to country, but its fundamental potential is obviously considerable.<\/jats:p>","DOI":"10.1111\/j.1423-0410.1978.tb02481.x","type":"journal-article","created":{"date-parts":[[2009,3,6]],"date-time":"2009-03-06T01:17:40Z","timestamp":1236302260000},"page":"261-275","source":"Crossref","is-referenced-by-count":14,"title":["Red Cells and Gelatin as the Core of a Unified Program for the National Procurement of Blood Components and Derivatives"],"prefix":"10.1111","volume":"34","author":[{"given":"P.","family":"Lundsgaard\u2010Hansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Bucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Tschirren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Haase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Kuske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"L\u00fcdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. A.","family":"Stankiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"H\u00e4ssig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,3,5]]},"reference":[{"key":"e_1_2_1_2_2","unstructured":"Aeberhard P.undBallmer P. M.:Kolloidosmotischer Druck Physiogelelimination und Eiweissrestitution in der postoperativen Phase;thesis Berne (1975)."},{"key":"e_1_2_1_3_2","volume-title":"The production and use of cellular blood components for transfusion","author":"Bucher U.","year":"1976"},{"key":"e_1_2_1_4_2","first-page":"761","article-title":"Die Erythrocyten\u2010transfusion","volume":"105","author":"Bucher U.","year":"1975","journal-title":"Schweiz. med. Wschr."},{"key":"e_1_2_1_5_2","unstructured":"Haase S.andL\u00fcdi H.:A sample analysis of blood usage in Switzerland as a background for the introduction of blood component therapy;thesis Berne (1976)."},{"key":"e_1_2_1_6_2","first-page":"238","article-title":"H\u00e4motherapie mit Plasmafraktionen (Albumin und Gammaglobulin)","volume":"5","author":"H\u00e4ssig A.","year":"1962","journal-title":"Triangel"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1107865"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1107874"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-197501000-00018"},{"key":"e_1_2_1_10_2","first-page":"592","article-title":"Colloid oncotic pressure and levels of albumin and total protein during major surgical procedures","volume":"143","author":"Howland W. S.","year":"1976","journal-title":"Surgery Gynec. Obstet."},{"key":"e_1_2_1_11_2","unstructured":"Kuske B.:The therapeutic safety of modified fluid gelatin as a plasma substitute. Incompatibility reactions and use in massive transfusions;thesis Berne (1978)."},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-197307000-00001"},{"key":"e_1_2_1_13_2","unstructured":"Lundsgaard\u2010Hansen P.:Optimum use of blood. 14th Congr. Int. Soc. Blood Transf. Helsinki1975. Book of Abstracts p.79."},{"key":"e_1_2_1_14_2","volume-title":"Transfusion and immunology","author":"Lundsgaard\u2010Hansen P.","year":"1975"},{"key":"e_1_2_1_15_2","first-page":"242","volume-title":"Oncotic deficit and albumin treatment","author":"Lundsgaard\u2010Hansen P.","year":"1975"},{"key":"e_1_2_1_16_2","unstructured":"Lundsgaard\u2010Hansen P.andThor\u00e9n L.:Scientific basis and clinical guidelines for the use of albumin plasma protein solutions and plasma substitutes; cit.O'Riordan et al.[19]."},{"key":"e_1_2_1_17_2","volume-title":"Blood substitutes and plasma expanders","author":"Lundsgaard\u2010Hansen P.","year":"1978"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-197111000-00010"},{"key":"e_1_2_1_19_2","volume-title":"Metabolic care of the surgical patient","author":"Moore F. D.","year":"1959"},{"key":"e_1_2_1_20_2","volume-title":"The indications for the use of albumin, plasma protein solutions, and plasma substitutes","author":"O'Riordan J.","year":"1976"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-197505000-00037"},{"key":"e_1_2_1_22_2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/milmed\/142.1.49","article-title":"Blood transfusion therapy in the rear hospital during the Yom Kippur War (October 1973)","volume":"142","author":"Sandler S. G.","year":"1977","journal-title":"Milit. Med."},{"key":"e_1_2_1_23_2","first-page":"621","article-title":"Sicherer und kostenbewusster Blutersatz","volume":"43","author":"Schvvarz H.","year":"1976","journal-title":"Helv. chir. Acta"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-197508000-00008"},{"key":"e_1_2_1_25_2","unstructured":"Stampfli K.:Sichere und kostenbewusste Versorgung der Schweizer H\u00e4mophilen mit Faktor VIII Mangel mit AHF\u2010Pr\u00e4paraten.Ther. Umschau(in press)."},{"key":"e_1_2_1_26_2","unstructured":"Stankiewicz L. A.:The clinical application of a blood component program to the treatment of surgical hemorrhage;thesis Berne (1977)."},{"key":"e_1_2_1_27_2","first-page":"651","article-title":"Der klinische Plasmaersatz mit Gelatine. Zw\u00f6lf Jahre Erfahrungen mit 39 320 Einheiten Physiogel","volume":"1","author":"Tschirren B.","year":"1973","journal-title":"Infusionstherapie"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.237.5.460"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-197501000-00001"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-76-6-987"},{"key":"e_1_2_1_31_2","first-page":"97","article-title":"Erythrocytensedimente als Volumenersatz in der Chirurgie","volume":"42","author":"Wiesner H. R.","year":"1975","journal-title":"Helv. chir. Acta"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-197104000-00001"}],"container-title":["Vox Sanguinis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1423-0410.1978.tb02481.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1423-0410.1978.tb02481.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T20:49:43Z","timestamp":1699649383000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1423-0410.1978.tb02481.x"}},"subtitle":["Prediction, Performance, and Impact on Supply of Albumin and Factor VIII"],"short-title":[],"issued":{"date-parts":[[1978,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1978,5]]}},"alternative-id":["10.1111\/j.1423-0410.1978.tb02481.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1423-0410.1978.tb02481.x","archive":["Portico"],"relation":{},"ISSN":["0042-9007","1423-0410"],"issn-type":[{"value":"0042-9007","type":"print"},{"value":"1423-0410","type":"electronic"}],"subject":[],"published":{"date-parts":[[1978,5]]}}}